Delivery Order SPE2DB20D3101-SPE2DB23FRHB6
- Not listed
- This is a $1,885.88 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of 4560633797 - FIRST-OMEPRAZOLE 2 MG/ML SUSP 90ML, with an ultimate completion date of April 19, 2023. This order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to...
- This is a delivery order under a larger indefinite delivery contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The order is for the supply of 4565615949 - FIRST-OMEPRAZOLE 2 MG/ML SUSP 150ML, a prescription medication, at a ceiling value of $1,043.43. The delivery order has a firm fixed price and an ultimate completion date of August 29, 2024. This contract does not have a set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,282.56 firm fixed-price delivery order is for the supply of First-Omeprazole 2 mg/ml suspension with a completion date of December 27, 2022. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $2,326.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of 4560052860 - FIRST-OMEPRAZOLE 2 MG/ML SUSP 150ML, a pharmaceutical product, with a completion date of February 27, 2023. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,190.94 firm-fixed-price delivery order is for the supply of First-Omeprazole 2 mg/ml suspension, a specialty pharmaceutical product. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the delivery of Omeprazole 2 mg/mL suspension in 150 mL bottles. The contract, valued at $2,564.88, is a Firm Fixed Price Delivery Order with a completion date of September 12, 2024. The contract is not set aside for any specific business type. Amerisourcebergen, through its Corporate Office division, will provide this essential medical...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,560,594,942 units of Omeprazole DR 40 mg capsules. The contract is a Delivery Order with a Firm Fixed Price of $2,456.24 and an ultimate completion date of April 17, 2023. This contract is not designated as a set-aside. AmerisourceBergen holds a significant...
- This federal contract award is for the delivery of Omeprazole 2 mg/ml suspension in 300 ml bottles to the Defense Logistics Agency (DLA). The contract, valued at $2,184.96, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order with a firm fixed price and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,198,487 units of omeprazole delayed-release 40 mg capsules. The contract has a total ceiling value of $2,256.48 and a completion date of February 7, 2025. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award, with a value of $1,868.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Omeprazole 2 mg/ml suspension, a pharmaceutical product used to treat gastrointestinal conditions. The contract is a delivery order, with a firm fixed price pricing type, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRHB6Delivery Order
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $1,536.05. The contract is for the supply of 4560485221 - First-Omeprazole 2 mg/ml suspension in 90 ml bottles. The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has a firm fixed price pricing type and an ultimate completion date of April 5, 2023. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 4/4/23 |